State-by-State Psychedelic Legislation

Psychedelic policy activity across 41 U.S. states, covering 255 bills on psilocybin, MDMA, LSD, DMT, ibogaine, and mescaline.

Psychedelic legislation by state

Hawaii psychedelic legislation (21 bills)
Massachusetts psychedelic legislation (20 bills)
New York psychedelic legislation (19 bills)
Virginia psychedelic legislation (12 bills)
Iowa psychedelic legislation (12 bills)
Missouri psychedelic legislation (12 bills)
Connecticut psychedelic legislation (10 bills)
Oregon psychedelic legislation (8 bills)
Minnesota psychedelic legislation (8 bills)
Mississippi psychedelic legislation (8 bills)
New Hampshire psychedelic legislation (8 bills)
Vermont psychedelic legislation (7 bills)
Washington psychedelic legislation (7 bills)
Rhode Island psychedelic legislation (7 bills)
Oklahoma psychedelic legislation (7 bills)
West Virginia psychedelic legislation (7 bills)
California psychedelic legislation (6 bills)
Illinois psychedelic legislation (6 bills)
New Jersey psychedelic legislation (6 bills)
New Mexico psychedelic legislation (6 bills)
Maryland psychedelic legislation (6 bills)
Michigan psychedelic legislation (5 bills)
Utah psychedelic legislation (5 bills)
Colorado psychedelic legislation (5 bills)
Texas psychedelic legislation (5 bills)
Federal psychedelic legislation (5 bills)
Nevada psychedelic legislation (3 bills)
Nebraska psychedelic legislation (3 bills)
Kentucky psychedelic legislation (3 bills)
Georgia psychedelic legislation (3 bills)
North Carolina psychedelic legislation (2 bills)
Pennsylvania psychedelic legislation (2 bills)
Maine psychedelic legislation (2 bills)
Tennessee psychedelic legislation (2 bills)
Indiana psychedelic legislation (1 bill)
North Dakota psychedelic legislation (1 bill)
Arizona psychedelic legislation (1 bill)
Kansas psychedelic legislation (1 bill)
Louisiana psychedelic legislation (1 bill)
South Dakota psychedelic legislation (1 bill)
Idaho psychedelic legislation (1 bill)